Siemens Healthineers AG (OTCMKTS:SMMNY) Short Interest Update

Siemens Healthineers AG (OTCMKTS:SMMNY) was the target of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 50,368 shares, a decline of 59.9% from the July 15th total of 125,563 shares. Based on an average trading volume of 196,684 shares, the short-interest ratio is presently 0.3 days.

Siemens Healthineers Stock Up 1.0%

OTCMKTS SMMNY opened at $22.72 on Friday. The stock has a 50-day moving average of $20.48 and a 200 day moving average of $21.54. Siemens Healthineers has a twelve month low of $19.20 and a twelve month high of $28.92.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a research note on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.